HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Evaluation of hemodynamic changes in patients with primary arterial hypertension after treatment with a combination of pindolol and clopamide (Viskaldix)].

Abstract
In 35 patients with mild essential hypertension the influence of 9 week Viskaldix therapy on hemodynamics was evaluated. Twelve of them underwent repeated hemodynamic examinations after mean 13 months treatment. Viskaldix therapy lowered total peripheral resistance --TPR and there was no significant influence on the heart rate, stroke volume, and cardiac output. It was demonstrated that decrease of total peripheral resistance after treatment with Viskaldix was directly proportional to the initial values of TPR.
AuthorsB Wyrzykowski, K Suchecka-Rachoń
JournalKardiologia polska (Kardiol Pol) Vol. 34 Issue 5 Pg. 286-91 ( 1991) ISSN: 0022-9032 [Print] Poland
Vernacular TitleOcena zmian w dynamice krazenia u chorych z pierwotnym nadciśnieniem tetniczym po leczeniu trwałym połaczeniem pindololu z klopamidem (Viskaldix).
PMID1921111 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Antihypertensive Agents
  • Drug Combinations
  • clopamide, pindolol drug combination
  • Clopamide
  • Pindolol
Topics
  • Adult
  • Antihypertensive Agents (therapeutic use)
  • Clopamide (administration & dosage, therapeutic use)
  • Drug Combinations
  • Hemodynamics (drug effects, physiology)
  • Humans
  • Hypertension (drug therapy, physiopathology)
  • Male
  • Middle Aged
  • Pindolol (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: